$2.157
+0.146 (+6.77%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Atossa Therapeutics Inc (ATOS) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting ATOS is Strong sell.
Atossa Therapeutics Inc (ATOS) 20-Day simple moving average is 2.44, while Atossa Therapeutics Inc (ATOS) share price is $—, making it Sell.
Atossa Therapeutics Inc (ATOS) 60-Day simple moving average is 2.42, while Atossa Therapeutics Inc (ATOS) share price is $—, making it Sell.
Technical Analysis for ATOS
AI Technical ATOSAs of 2026-11-07, the technical board for Atossa Therapeutics Inc (ATOS) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $2.16 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 41.734, MACD stands at -0.0783 (Sell), Stochastic %K stands at 7.681 (Buy), Stochastic %D stands at 9.716 and CCI stands at -132.105 (Buy).
ATOS trades below the 60-day SMA (2.42) and below the 200-day SMA (3.77). Immediate resistance sits at Classic R1 2.59, then R2 2.93. Support sits at Classic S1 1.94, then S2 1.64.
Atossa Therapeutics Inc (ATOS) Support & Resistance Level
Atossa Therapeutics Inc (ATOS) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 41.734 |
| STOCHk_14_3_3 | 7.681 |
| STOCHd_14_3_3 | 9.716 |
| CCI_20 | -132.105 |
| AO_5_34 | -0.168 |
| MOM_10 | -0.480 |
| MACD_12_26_9 | -0.078 |
Atossa Therapeutics Inc (ATOS) Relative Strength Index (RSI_14) is 41.734, creating a Neutral signal.
Atossa Therapeutics Inc (ATOS) Stochastic %K is 7.681, creating a Buy signal.
Atossa Therapeutics Inc (ATOS) Stochastic %D is 9.716, creating a Buy signal.
Atossa Therapeutics Inc (ATOS) CCI_20 is -132.105, creating a Buy signal.
Atossa Therapeutics Inc (ATOS) Awesome Oscillator (AO) is -0.168, creating a Sell signal.
Atossa Therapeutics Inc (ATOS) Momentum (MOM) is -0.480, creating a Sell signal.
Atossa Therapeutics Inc (ATOS) Moving Average Convergence Divergence (MACD) is -0.078, creating a Sell signal.
Atossa Therapeutics Inc (ATOS) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 2.178 | Sell |
| MA_10 | 2.249 | Sell |
| MA_20 | 2.436 | Sell |
| MA_60 | 2.419 | Sell |
| MA_200 | 3.772 | Sell |
| MA_250 | 5.176 | Sell |
Atossa Therapeutics Inc (ATOS) 5-Day simple moving average is 2.178, while Atossa Therapeutics Inc (ATOS) share price is $, making it a Sell.
Atossa Therapeutics Inc (ATOS) 10-Day simple moving average is 2.249, while Atossa Therapeutics Inc (ATOS) share price is $, making it a Sell.
Atossa Therapeutics Inc (ATOS) 20-Day simple moving average is 2.436, while Atossa Therapeutics Inc (ATOS) share price is $, making it a Sell.
Atossa Therapeutics Inc (ATOS) 60-Day simple moving average is 2.419, while Atossa Therapeutics Inc (ATOS) share price is $, making it a Sell.
Atossa Therapeutics Inc (ATOS) 200-Day simple moving average is 3.772, while Atossa Therapeutics Inc (ATOS) share price is $, making it a Sell.
Atossa Therapeutics Inc (ATOS) 250-Day simple moving average is 5.176, while Atossa Therapeutics Inc (ATOS) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.